To further investigate the mediation of the NF-κB pathway in the deterioration effect of PEBP4 deletion on liver fibrosis, we firstly examined the effect of PDTC, an NF-κB pathway inhibitor, on liver fibrosis induced by CCl4. The gene discussed is PEBP4; the disease is Hepatic fibrosis.